Cargando…

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia

Background: A higher risk for COVID-19 infection and severity for men compared to women has been described since the beginning of the pandemic. The role of androgens has been recently highlighted as they control two key steps of coronavirus infection mediated through the transmembrane protease serin...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnieri, Gabriella, Bertagna De Marchi, Leonardo, Marcon, Alessandro, Panunzi, Silvia, Batani, Veronica, Caminati, Marco, Furci, Fabiana, Senna, Gianenrico, Alaibac, Mauro, Vianello, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959503/
https://www.ncbi.nlm.nih.gov/pubmed/35341398
http://dx.doi.org/10.1080/07853890.2022.2054026
_version_ 1784677169353457664
author Guarnieri, Gabriella
Bertagna De Marchi, Leonardo
Marcon, Alessandro
Panunzi, Silvia
Batani, Veronica
Caminati, Marco
Furci, Fabiana
Senna, Gianenrico
Alaibac, Mauro
Vianello, Andrea
author_facet Guarnieri, Gabriella
Bertagna De Marchi, Leonardo
Marcon, Alessandro
Panunzi, Silvia
Batani, Veronica
Caminati, Marco
Furci, Fabiana
Senna, Gianenrico
Alaibac, Mauro
Vianello, Andrea
author_sort Guarnieri, Gabriella
collection PubMed
description Background: A higher risk for COVID-19 infection and severity for men compared to women has been described since the beginning of the pandemic. The role of androgens has been recently highlighted as they control two key steps of coronavirus infection mediated through the transmembrane protease serin 2 (TMPRRS2) and the angiotensin-converting enzyme 2 (ACE2) receptor in the lung tissue. Furthermore, a high incidence of androgenic alopecia among males with COVID-19 disease have been reported. Objective: This study aims to evaluate the telogen effluvium (TE) prevalence and its relationship with clinical and immunologic parameters in a sample of patients consecutively evaluated after recovery from COVID-19 pneumonia in Northern Italy. Methods: Overall 104 patients were recruited within three months from COVID-19 pneumonia recovery; 80 (77%) had been hospitalized in a Respiratory Intensive Care Unit and the remaining ones had been treated at home. The extent of TE was assessed with a visual analogic scale for thick bundle of hairs. Demographic and clinical data and systemic inflammation biomarkers were also evaluated. Results. Thirty-two patients reported a history of TE and their mean TE-VAS score was 5.78 ± 1.72 (range 3–9). Women had about a 5-fold higher risk (odds) of complaining of TE compared to males (OR = 4.69, 95%CI: 1.91, 11.49; p = .001), and the association became stronger when adjusted for COVID-19 severity (hospital admission vs home care: OR = 6.09, 95%CI: 2.34, 15.88; p < .001). Levels of C-reactive protein >1.90 mg/l (OR(adj): 2.43, 95%CI 0.85, 7.05, p = 0.096) or IL 1β > 5 ng/l (OR(adj) 4.72, 95%CI: 1.31, 23.19, p = .03) were also significantly associated with TE. Conclusion: KEY MESSAGES: The presence of Telogen effluvium (TE) was significantly more common in women. Higher severity of the Covid-19 disease seems to play a critical role, more important than the hormonal influence, in the development of TE. The severity of inflammation related to TE and Covid-19 could also play a role as suggested by the higher levels of CRP and platelets and IL1β.
format Online
Article
Text
id pubmed-8959503
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89595032022-03-29 Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia Guarnieri, Gabriella Bertagna De Marchi, Leonardo Marcon, Alessandro Panunzi, Silvia Batani, Veronica Caminati, Marco Furci, Fabiana Senna, Gianenrico Alaibac, Mauro Vianello, Andrea Ann Med Dermatology Background: A higher risk for COVID-19 infection and severity for men compared to women has been described since the beginning of the pandemic. The role of androgens has been recently highlighted as they control two key steps of coronavirus infection mediated through the transmembrane protease serin 2 (TMPRRS2) and the angiotensin-converting enzyme 2 (ACE2) receptor in the lung tissue. Furthermore, a high incidence of androgenic alopecia among males with COVID-19 disease have been reported. Objective: This study aims to evaluate the telogen effluvium (TE) prevalence and its relationship with clinical and immunologic parameters in a sample of patients consecutively evaluated after recovery from COVID-19 pneumonia in Northern Italy. Methods: Overall 104 patients were recruited within three months from COVID-19 pneumonia recovery; 80 (77%) had been hospitalized in a Respiratory Intensive Care Unit and the remaining ones had been treated at home. The extent of TE was assessed with a visual analogic scale for thick bundle of hairs. Demographic and clinical data and systemic inflammation biomarkers were also evaluated. Results. Thirty-two patients reported a history of TE and their mean TE-VAS score was 5.78 ± 1.72 (range 3–9). Women had about a 5-fold higher risk (odds) of complaining of TE compared to males (OR = 4.69, 95%CI: 1.91, 11.49; p = .001), and the association became stronger when adjusted for COVID-19 severity (hospital admission vs home care: OR = 6.09, 95%CI: 2.34, 15.88; p < .001). Levels of C-reactive protein >1.90 mg/l (OR(adj): 2.43, 95%CI 0.85, 7.05, p = 0.096) or IL 1β > 5 ng/l (OR(adj) 4.72, 95%CI: 1.31, 23.19, p = .03) were also significantly associated with TE. Conclusion: KEY MESSAGES: The presence of Telogen effluvium (TE) was significantly more common in women. Higher severity of the Covid-19 disease seems to play a critical role, more important than the hormonal influence, in the development of TE. The severity of inflammation related to TE and Covid-19 could also play a role as suggested by the higher levels of CRP and platelets and IL1β. Taylor & Francis 2022-03-26 /pmc/articles/PMC8959503/ /pubmed/35341398 http://dx.doi.org/10.1080/07853890.2022.2054026 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Dermatology
Guarnieri, Gabriella
Bertagna De Marchi, Leonardo
Marcon, Alessandro
Panunzi, Silvia
Batani, Veronica
Caminati, Marco
Furci, Fabiana
Senna, Gianenrico
Alaibac, Mauro
Vianello, Andrea
Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
title Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
title_full Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
title_fullStr Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
title_full_unstemmed Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
title_short Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
title_sort relationship between hair shedding and systemic inflammation in covid-19 pneumonia
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959503/
https://www.ncbi.nlm.nih.gov/pubmed/35341398
http://dx.doi.org/10.1080/07853890.2022.2054026
work_keys_str_mv AT guarnierigabriella relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT bertagnademarchileonardo relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT marconalessandro relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT panunzisilvia relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT bataniveronica relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT caminatimarco relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT furcifabiana relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT sennagianenrico relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT alaibacmauro relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia
AT vianelloandrea relationshipbetweenhairsheddingandsystemicinflammationincovid19pneumonia